Frazier Healthcare Partners Announces the Promotions of Christina Reszka and Philip Zaorski to Partner
SEATTLE, January 20, 2022-- Frazier Healthcare Partners, a leading healthcare investment firm, today announced the promotions of Christina Reszka and Philip Zaorski to Partner on the Growth Buyout team.
Ms. Reszka joined Frazier Healthcare Partners in 2019 as a Principal on the Growth Buyout team. She represents Frazier on the boards of Accuity Delivery Systems and United Derm Partners. Christina has been instrumental in our Diversity, Equity, Inclusion and Advancement Team efforts, as well as internal recruitment and mentoring endeavors. Before Frazier, Ms. Reszka spent ten years at Norwest Equity Partners and prior to that she spent time at Craig-Hallum and LaSalle Bank. Ms. Reszka holds a B.S.B. in Finance and Marketing from the University of Minnesota and an M.B.A. from Harvard University.
Mr. Zaorski joined Frazier in 2012 and represents Frazier on the boards of CPS Solutions, CSafe Global, SunMed, and Vein Clinics of America. In addition, he played an instrumental role in several of Frazier’s exited portfolio companies, including DSI Renal, Golden State Medical Supply, Northfield Medical, and The CORE Institute. Since starting with Frazier nine years ago, Phil has been an integral part of our team and has played an important role in our growth over the past several years. Prior to Frazier, he was with RBC Capital Markets, and he holds a B.S. from the Wharton School of Business at the University of Pennsylvania.
"We are pleased to congratulate Christina and Phil on their well-deserved promotions to Partner. Both have demonstrated strong leadership on a variety of transactions and in working with our portfolio company management teams to execute strategic growth plans,” said Ben Magnano, Managing Partner. “Both are tremendously valuable team members and, as the next generation of leadership at Frazier, they will help drive our continued growth and evolution as a firm.”
About Frazier Healthcare Partners:
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With over $7 billion in total capital raised, Frazier has invested in more than 200 companies with transaction types ranging from buyouts of profitable healthcare services companies to venture capital and company creation. Frazier has a philosophy of partnering with strong management teams while leveraging its internal operating resources and network to build exceptional companies. Frazier has offices in Seattle, WA, and Menlo Park, CA, and invests broadly across the U.S., Canada, and Europe.
For more information about Frazier Healthcare Partners, visit www.frazierhealthcare.com.
Frazier Healthcare Partners
Carol Eckert, VP of Investor Relations
Venture Capital Database